Indications and uses
relieves occasional constipation (irregulatiry) generally causes bowel movement in 6-12 hours
relieves occasional constipation (irregulatiry) generally causes bowel movement in 6-12 hours
take preferably at bedtime or as directed by a doctor if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease does until you are comfortable Age starting dosage maximum dosage adults children 12 years and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tabelts twice a day children 2 ...
Drug Facts
Sennosides 8.6 mg
Stimulant Laxative
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach children. In case of overdose, get medical help or contact a Poison Control Center right away.
| Age | starting dosage | maximum dosage |
| adults children 12 years and over | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tabelts twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil
Call 516-341-0666, 8:30 am - 4:30 pm ET, Monday - Friday
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 45865-971-30 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8cdc-d83d-e063-dadaa90ab31f | Senna |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45865-971-30 | Senna | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69618-048-01 | EA - Each | 69618-048 | a8353b4a-21ae-43ea-a248-c52728b22d1d | 1 | 2019-01-24 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 45865-971 | 45865-971-30 |
| 69618-048 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9af0b870-0df4-9692-e053-2995a90ac5ab | 9af0b870-0df3-9692-e053-2995a90ac5ab | 2019-12-30 | Warnings | 9af0b870-0df4-9692-e053-2995a90ac5ab 9af0b870-0df3-9692-e053-2995a90ac5ab |
Adverse event summaries are temporarily unavailable. Other product information remains available.